2017 American Transplant Congress
TNF[part]-I After Kidney Transplantation.
Department of Medicine, Division of Nephrology, University of Wisconsin, Madison, WI
Infliximab, adalimumab and etanercept are monoclonal antibodies which inhibit tumor necrosis factor alpha (TNF[part]-I) and are used in the treatment of inflammatory diseases such as…2017 American Transplant Congress
The Effiency and Safety of Chemotherapy for Urothelial Carcinoma in Post-Kidney Transplanted Patients.
Urology, Capital Medical University Beijing Friendship Hospital, Beijing, China
Objective: According to our published data, upper tract urothelial carcinoma (UTUC) is the predominant malignancy among Chinese renal transplanted patients. This is quite different from…2017 American Transplant Congress
Analysis of ApoL1 and MYH9 Genetic Polymorphisms Among the Hispanic Kidney Allograft Recipients.
Introduction: Genetic polymorphisms of Apolipoprotein 1 (ApoL1) and non-muscle heavy chain 9 (MYH9) genes are known to be strongly associated with focal segmental glomerulosclerosis, HIV-associated…2017 American Transplant Congress
Personalized Tacrolimus (TAC) Dosing Using Genetic Variants in Caucasian Kidney Transplant (Tx) Recipients.
TAC is an immune suppressant with a narrow therapeutic index and high pharmacokinetic (PK) variability leading to uncertainty in blood concentrations. We previously developed an…2017 American Transplant Congress
Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Dosing.
Bodyweight-based dosing of tacrolimus (Tac) is considered standard care, even though the available evidence is thin. An increasing proportion of transplant recipients is overweight, prompting…2017 American Transplant Congress
Pre-Transplant Panel Reactive T Cells (PRT) with IL-15 as a Risk-Stratifier of Acute Rejection in Kidney Transplant Patients on Belatacept Therapy.
While kidney transplant recipients treated with bela without calcineurin inhibitors (CNI) have better 5-10y eGFR versus those on CNI, Belatacept (bela) use is associated with…2017 American Transplant Congress
Obesity Is an Important Factor in Deceased but Not Living Donor Kidney Transplants.
Cardiff Transplant Unit, University Hospital of Wales, Cardiff, United Kingdom
Introduction There is an increasing obesity among potential kidney transplant recipients. We had in the past shown that obesity did increase the wound infection rate,…2017 American Transplant Congress
Single Kidney Transplantation from Pediatric Donors Younger Than 3 Years to Adult Recipients.
Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Background: Traditionally, the criteria of splitting pediatric en bloc kidneys for transplantation into two adults includes: donor age > 3 years, donor weight > 12kg,…2017 American Transplant Congress
Comparison of the Estimated and Measured Glomerular Filtration Rate in Kidney Donor Candidates.
Nephrology, Houston Methodist Hospital, Houston, TX
Background and objectivesThe assessment of GFR in kidney donor candidates is necessary for the appropriate allocation of donor kidneys to recipients. This assessment can be…2017 American Transplant Congress
Prospective Monitoring of 25-Hydroxyvitamin Vitamin D Levels After Kidney Transplantation and Its Associations with Clinical Outcomes.
Montefiore Transplant Center, Albert Einstein College of Medicine, Bronx, NY
Background: Kidney transplant recipients usually have low vitamin D levels. Vitamin D deficiency is recognized as a risk factor for progression of kidney disease in…
- « Previous Page
- 1
- …
- 380
- 381
- 382
- 383
- 384
- …
- 531
- Next Page »